427 related articles for article (PubMed ID: 14670849)
1. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
[TBL] [Abstract][Full Text] [Related]
2. Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes.
Pohlmann L; Kröger I; Vignier N; Schlossarek S; Krämer E; Coirault C; Sultan KR; El-Armouche A; Winegrad S; Eschenhagen T; Carrier L
Circ Res; 2007 Oct; 101(9):928-38. PubMed ID: 17823372
[TBL] [Abstract][Full Text] [Related]
3. Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy.
Flagg TP; Cazorla O; Remedi MS; Haim TE; Tones MA; Bahinski A; Numann RE; Kovacs A; Schaffer JE; Nichols CG; Nerbonne JM
Circ Res; 2009 Jan; 104(1):95-103. PubMed ID: 19023131
[TBL] [Abstract][Full Text] [Related]
4. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model.
Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M
Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225
[TBL] [Abstract][Full Text] [Related]
5. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
Knollmann BC; Kirchhof P; Sirenko SG; Degen H; Greene AE; Schober T; Mackow JC; Fabritz L; Potter JD; Morad M
Circ Res; 2003 Mar; 92(4):428-36. PubMed ID: 12600890
[TBL] [Abstract][Full Text] [Related]
6. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
[TBL] [Abstract][Full Text] [Related]
7. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
Kraft T; Witjas-Paalberends ER; Boontje NM; Tripathi S; Brandis A; Montag J; Hodgkinson JL; Francino A; Navarro-Lopez F; Brenner B; Stienen GJ; van der Velden J
J Mol Cell Cardiol; 2013 Apr; 57():13-22. PubMed ID: 23318932
[TBL] [Abstract][Full Text] [Related]
8. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy.
Tsoutsman T; Chung J; Doolan A; Nguyen L; Williams IA; Tu E; Lam L; Bailey CG; Rasko JE; Allen DG; Semsarian C
J Mol Cell Cardiol; 2006 Oct; 41(4):623-32. PubMed ID: 16950368
[TBL] [Abstract][Full Text] [Related]
9. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA
Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629
[TBL] [Abstract][Full Text] [Related]
10. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
[TBL] [Abstract][Full Text] [Related]
11. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.
Iorga B; Blaudeck N; Solzin J; Neulen A; Stehle I; Lopez Davila AJ; Pfitzer G; Stehle R
Cardiovasc Res; 2008 Mar; 77(4):676-86. PubMed ID: 18096573
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation.
Georgakopoulos D; Christe ME; Giewat M; Seidman CM; Seidman JG; Kass DA
Nat Med; 1999 Mar; 5(3):327-30. PubMed ID: 10086390
[TBL] [Abstract][Full Text] [Related]
13. Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations.
Coutu P; Bennett CN; Favre EG; Day SM; Metzger JM
Circ Res; 2004 May; 94(9):1235-41. PubMed ID: 15059934
[TBL] [Abstract][Full Text] [Related]
14. The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.
Semsarian C; Ahmad I; Giewat M; Georgakopoulos D; Schmitt JP; McConnell BK; Reiken S; Mende U; Marks AR; Kass DA; Seidman CE; Seidman JG
J Clin Invest; 2002 Apr; 109(8):1013-20. PubMed ID: 11956238
[TBL] [Abstract][Full Text] [Related]
15. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
[TBL] [Abstract][Full Text] [Related]
16. A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.
Semsarian C; Healey MJ; Fatkin D; Giewat M; Duffy C; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2001 Nov; 33(11):2055-60. PubMed ID: 11708849
[TBL] [Abstract][Full Text] [Related]
17. Overexpressed cardiac Gsalpha in rabbits.
Nishizawa T; Vatner SF; Hong C; Shen YT; Hardt SE; Robbins J; Ishikawa Y; Sadoshima J; Vatner DE
J Mol Cell Cardiol; 2006 Jul; 41(1):44-50. PubMed ID: 16678849
[TBL] [Abstract][Full Text] [Related]
18. Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics.
Haim TE; Dowell C; Diamanti T; Scheuer J; Tardiff JC
J Mol Cell Cardiol; 2007 Jun; 42(6):1098-110. PubMed ID: 17490679
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly.
Ai J; Zhang R; Gao X; Niu HF; Wang N; Xu Y; Li Y; Ma N; Sun LH; Pan ZW; Li WM; Yang BF
Cardiovasc Res; 2012 Aug; 95(3):385-93. PubMed ID: 22719074
[TBL] [Abstract][Full Text] [Related]
20. A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice.
Prabhakar R; Boivin GP; Grupp IL; Hoit B; Arteaga G; Solaro RJ; Wieczorek DF
J Mol Cell Cardiol; 2001 Oct; 33(10):1815-28. PubMed ID: 11603924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
